| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Research Communications |
a Modulo Progressione Neoplastica, the
b Servizio di Farmacologia e Neuroscienze, Istituto Nazionale per la Ricerca sul Cancro, the
c Sezione di Farmacologia, Dept of Oncologia, Univ. of Genova, and the
d Centro di Biotecnologie Avanzate, 16132 Genova, Italy
Somatostatin and its analogs are active in the inhibition of SST receptor-positive endocrine neoplasms, but their activity and mechanism in nonendocrine tumors is not clear. Somatostatin potently inhibited growth of a Kaposi's sarcoma xenograft in nude mice, yet in vitro the tumor cells did not express any known somatostatin receptors and were not growth inhibited by somatostatin. Histological examination revealed limited vascularization in the somatostatin-treated tumors as compared with the controls. Somatostatin was a potent inhibitor of angiogenesis in an in vivo assay. In vitro, somatostatin inhibited endothelial cell growth and invasion. Migration of monocytes, important mediators of the angiogenic cascade, was also inhibited by somatostatin. Both cells types expressed somatostatin receptor mRNAs. These data demonstrate that somatostatin is a potent antitumor angiogenesis compound directly affecting both endothelial and monocytic cells. The debated function of somatostatin in tumor treatment and the design of therapeutic protocols should be reexamined considering these data.—Albini, A., Florio, T., Giunciuglio, D., Masiello, L., Carlone, S., Corsaro, A., Thellung, S., Cai, T., Noonan, D. M., Schettini, G. Somatostatin controls Kaposi's sarcoma tumor growth through inhibition of angiogenesis.
Key Words: endothelial cells • monocytes • macrophages • invasion • neovascularization • somatostatin receptors
This article has been cited by other articles:
|
|
 |
|
  S. Grozinsky-Glasberg, I. Shimon, M. Korbonits, and A. B Grossman Somatostatin analogues in the control of neuroendocrine tumours: efficacy and mechanisms Endocr. Relat. Cancer, September 1, 2008; 15(3): 701 - 720. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Barbieri, A. Pattarozzi, M. Gatti, C. Porcile, A. Bajetto, A. Ferrari, M. D. Culler, and T. Florio Somatostatin Receptors 1, 2, and 5 Cooperate in the Somatostatin Inhibition of C6 Glioma Cell Proliferation in Vitro via a Phosphotyrosine Phosphatase-{eta}-Dependent Inhibition of Extracellularly Regulated Kinase-1/2 Endocrinology, September 1, 2008; 149(9): 4736 - 4746. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Arena, A. Pattarozzi, A. Massa, J.-P. Esteve, R. Iuliano, A. Fusco, C. Susini, and T. Florio An Intracellular Multi-Effector Complex Mediates Somatostatin Receptor 1 Activation of Phospho-Tyrosine Phosphatase {eta} Mol. Endocrinol., January 1, 2007; 21(1): 229 - 246. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. O'Toole, A. Saveanu, A. Couvelard, G. Gunz, A. Enjalbert, P. Jaquet, P. Ruszniewski, and A. Barlier The analysis of quantitative expression of somatostatin and dopamine receptors in gastro-entero-pancreatic tumours opens new therapeutic strategies Eur. J. Endocrinol., December 1, 2006; 155(6): 849 - 857. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Arena, A. Pattarozzi, A. Corsaro, G. Schettini, and T. Florio Somatostatin Receptor Subtype-Dependent Regulation of Nitric Oxide Release: Involvement of Different Intracellular Pathways Mol. Endocrinol., January 1, 2005; 19(1): 255 - 267. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. MASSA, F. BARBIERI, C. AIELLO, R. IULIANO, S. ARENA, A. PATTAROZZI, A. CORSARO, V. VILLA, A. FUSCO, G. ZONA, et al. The Phosphotyrosine Phosphatase {eta} Mediates Somatostatin Inhibition of Glioma Proliferation via the Dephosphorylation of ERK1/2 Ann. N.Y. Acad. Sci., December 1, 2004; 1030(1): 264 - 274. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H Reynaert, K Rombouts, A Vandermonde, D Urbain, U Kumar, P Bioulac-Sage, M Pinzani, J Rosenbaum, and A Geerts Expression of somatostatin receptors in normal and cirrhotic human liver and in hepatocellular carcinoma Gut, August 1, 2004; 53(8): 1180 - 1189. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Massa, F. Barbieri, C. Aiello, S. Arena, A. Pattarozzi, P. Pirani, A. Corsaro, R. Iuliano, A. Fusco, G. Zona, et al. The Expression of the Phosphotyrosine Phosphatase DEP-1/PTP{eta} Dictates the Responsivity of Glioma Cells to Somatostatin Inhibition of Cell Proliferation J. Biol. Chem., July 9, 2004; 279(28): 29004 - 29012. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N D Stafford, L T Condon, M J C Rogers, L Helboe, D A Crooks, and S L Atkin The immunohistochemical localisation of somatostatin receptors 1, 2, 3, and 5 in acoustic neuromas J. Clin. Pathol., February 1, 2004; 57(2): 168 - 171. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Pola, M. G. Cattaneo, and L. M. Vicentini Anti-migratory and Anti-invasive Effect of Somatostatin in Human Neuroblastoma Cells: INVOLVEMENT OF RAC AND MAP KINASE ACTIVITY J. Biol. Chem., October 17, 2003; 278(42): 40601 - 40606. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. A. S. H. Dalm, P. M. van Hagen, P. M. van Koetsveld, S. Achilefu, A. B. Houtsmuller, D. H. J. Pols, A.-J. van der Lely, S. W. J. Lamberts, and L. J. Hofland Expression of somatostatin, cortistatin, and somatostatin receptors in human monocytes, macrophages, and dendritic cells Am J Physiol Endocrinol Metab, August 1, 2003; 285(2): E344 - E353. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Florio, M. Morini, V. Villa, S. Arena, A. Corsaro, S. Thellung, M. D. Culler, U. Pfeffer, D. M. Noonan, G. Schettini, et al. Somatostatin Inhibits Tumor Angiogenesis and Growth via Somatostatin Receptor-3-Mediated Regulation of Endothelial Nitric Oxide Synthase and Mitogen-Activated Protein Kinase Activities Endocrinology, April 1, 2003; 144(4): 1574 - 1584. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. J. Buchan, C.-Y. Lin, J. Choi, and D. L. Barber Somatostatin, Acting at Receptor Subtype 1, Inhibits Rho Activity, the Assembly of Actin Stress Fibers, and Cell Migration J. Biol. Chem., August 2, 2002; 277(32): 28431 - 28438. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Zhang and A. C. Issekutz Down-Modulation of Monocyte Transendothelial Migration and Endothelial Adhesion Molecule Expression by Fibroblast Growth Factor : Reversal by the Anti-Angiogenic Agent SU6668 Am. J. Pathol., June 1, 2002; 160(6): 2219 - 2230. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Albini, M. Morini, F. D'Agostini, N. Ferrari, F. Campelli, G. Arena, D. M. Noonan, C. Pesce, and S. De Flora Inhibition of Angiogenesis-driven Kaposi's Sarcoma Tumor Growth in Nude Mice by Oral N-Acetylcysteine Cancer Res., November 1, 2001; 61(22): 8171 - 8178. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Florio, S. Arena, S. Thellung, R. Iuliano, A. Corsaro, A. Massa, A. Pattarozzi, A. Bajetto, F. Trapasso, A. Fusco, et al. The Activation of the Phosphotyrosine Phosphatase {eta} (r-PTP{eta}) Is Responsible for the Somatostatin Inhibition of PC Cl3 Thyroid Cell Proliferation Mol. Endocrinol., October 1, 2001; 15(10): 1838 - 1852. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Indraccolo, M. Morini, E. Gola, F. Carrozzino, W. Habeler, S. Minghelli, L. Santi, L. Chieco-Bianchi, Y. Cao, A. Albini, et al. Effects of Angiostatin Gene Transfer on Functional Properties and in Vivo Growth of Kaposi's Sarcoma Cells Cancer Res., July 1, 2001; 61(14): 5441 - 5446. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Sodhi, S. Montaner, V. Patel, M. Zohar, C. Bais, E. A. Mesri, and J. S. Gutkind The Kaposi's Sarcoma-associated Herpes Virus G Protein-coupled Receptor Up-Regulates Vascular Endothelial Growth Factor Expression and Secretion through Mitogen-activated Protein Kinase and p38 Pathways Acting on Hypoxia-inducible Factor 1{{alpha}} Cancer Res., September 1, 2000; 60(17): 4873 - 4880. [Abstract] [Full Text]
|
|
|
|
|
|
A. Albini, C. Marchisone, F. Del Grosso, R. Benelli, L. Masiello, C. Tacchetti, M. Bono, M. Ferrantini, C. Rozera, M. Truini, et al. Inhibition of Angiogenesis and Vascular Tumor Growth by Interferon-Producing Cells : A Gene Therapy Approach Am. J. Pathol., April 1, 2000; 156(4): 1381 - 1393. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
